Financial Statements · From SEC 10-K & 10-Q XBRL Filings
Core Scientific Inc. Revenue & Financial Statements
Core Scientific Inc. reported revenue of $319.0M for the fiscal year ended December 31, 2025, down 37.5% year over year, with net income of $(288.6M) and diluted EPS of $-0.88.
- Company
- Core Scientific Inc. CORZ · NASDAQ
- Latest fiscal year
- FY ended Dec 31, 2025
- Statements
- Income · Balance Sheet · Cash Flow — 5 fiscal years, 8 quarters
Income Statement
Annual, as reported in 10-K filings. Values in USD.
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | — | 640.3M | 502.4M | 510.7M | 319.0M |
| Cost of revenue | — | 631.9M | 378.9M | 389.6M | 281.1M |
| Gross profit | — | 8.4M | 123.5M | 121.1M | 37.9M |
| Operating income | (5.2M) | (2.1B) | 9.0M | (19.2M) | (245.6M) |
| Pretax income | — | (2.2B) | (245.8M) | (1.3B) | 0 |
| Net income | (32.5M) | (2.1B) | (246.5M) | (1.3B) | (288.6M) |
| Diluted EPS | — | -6.30 | -0.65 | -4.39 | -0.88 |
| EBITDA | — | (1.9B) | 105.0M | 94.0M | (176.7M) |
Quarterly
| USD | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 179.3M | 141.1M | 95.4M | 94.9M | 79.5M | 78.6M | 81.1M | 79.8M |
| Cost of revenue | 101.6M | 102.3M | 95.5M | 90.2M | 71.3M | 73.6M | 77.2M | 59.0M |
| Gross profit | 77.6M | 38.8M | (156K) | 4.8M | 8.2M | 5.0M | 3.9M | 20.8M |
| Operating income | 55.2M | 6.6M | (41.2M) | (39.8M) | (42.6M) | (26.3M) | (57.4M) | (119.3M) |
| Pretax income | 210.9M | (804.8M) | (455.1M) | (265.2M) | 580.9M | (936.6M) | (146.5M) | 214.2M |
| Net income | 210.7M | (804.9M) | (455.3M) | (265.5M) | 580.7M | (936.8M) | (146.7M) | 214.2M |
| Diluted EPS | 0.78 | -4.51 | -1.17 | -0.68 | 1.25 | -0.04 | -0.46 | 0.60 |
| EBITDA | 84.2M | — | (12.5M) | (13.7M) | (22.9M) | — | (41.1M) | (105.2M) |
Balance Sheet
Fiscal year-end snapshots. Values in USD.
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Total assets | 346.4M | 807.7M | 712.2M | 1.6B | 2.3B |
| Current assets | 1.3M | 85.1M | 97.0M | 904.0M | 895.5M |
| Cash & equivalents | 971K | 15.9M | 50.4M | 836.2M | 311.4M |
| Total liabilities | 65.6M | 1.2B | 1.3B | 2.4B | 3.3B |
| Current liabilities | 4.2M | 186.8M | 488.4M | 134.6M | 781.4M |
| Long-term debt | — | — | — | — | — |
| Total debt | — | — | — | — | — |
| Stockholders’ equity | (64.2M) | (409.3M) | (596.9M) | (820.2M) | (962.7M) |
| Net debt | — | — | — | — | — |
Cash Flow Statement
Annual, as reported in 10-K filings. Values in USD.
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Operating cash flow | (1.9M) | 205.2M | 65.1M | 42.9M | 278.2M |
| Investing cash flow | (345.0M) | (590.8M) | (3.0M) | (95.2M) | (740.8M) |
| Financing cash flow | 347.8M | 306.2M | (44.6M) | 819.6M | (63.1M) |
| Capital expenditure | — | 384.0M | 16.2M | 95.0M | 729.0M |
| Free cash flow | — | (178.8M) | 49.0M | (52.1M) | (450.8M) |
| Dividends paid | — | — | — | — | — |
| Stock-based compensation | — | 182.9M | 58.9M | 51.9M | 98.2M |
Figures are parsed from SEC XBRL company facts and may be derived where issuers report year-to-date values (quarterly figures differenced; Q4 computed as FY minus Q3). Fiscal periods follow each company's fiscal calendar, not calendar years. Historical fact, not investment advice — verify with official SEC filings.
Every CORZ filing, connected
Financials beside price, insider trades, and 8-K events — with alerts the moment something new is filed.